- Home
- TLSI vs LANV Comparison
TLSI vs LANV Comparison
Compare TLSI & LANV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- LANV
- Stock Information
- Founded
- TLSI 2010
- LANV 2015
- Country
- TLSI United States
- LANV China
- Employees
- TLSI N/A
- LANV N/A
- Industry
- TLSI Medical Specialities
- LANV Blank Checks
- Sector
- TLSI Health Care
- LANV Finance
- Exchange
- TLSI Nasdaq
- LANV Nasdaq
- Market Cap
- TLSI 166.8M
- LANV 196.8M
- IPO Year
- TLSI N/A
- LANV N/A
- Fundamental
- Price
- TLSI $4.67
- LANV $1.70
- Analyst Decision
- TLSI Strong Buy
- LANV
- Analyst Count
- TLSI 3
- LANV 0
- Target Price
- TLSI $12.67
- LANV N/A
- AVG Volume (30 Days)
- TLSI 77.7K
- LANV 91.2K
- Earning Date
- TLSI 11-12-2024
- LANV 08-26-2024
- Dividend Yield
- TLSI N/A
- LANV N/A
- EPS Growth
- TLSI N/A
- LANV N/A
- EPS
- TLSI N/A
- LANV N/A
- Revenue
- TLSI $24,736,000.00
- LANV $409,961,427.00
- Revenue This Year
- TLSI $61.24
- LANV N/A
- Revenue Next Year
- TLSI $47.32
- LANV $76.77
- P/E Ratio
- TLSI N/A
- LANV N/A
- Revenue Growth
- TLSI 67.75
- LANV N/A
- 52 Week Low
- TLSI $3.32
- LANV $0.91
- 52 Week High
- TLSI $10.42
- LANV $4.70
- Technical
- Relative Strength Index (RSI)
- TLSI 36.08
- LANV 51.97
- Support Level
- TLSI $4.43
- LANV $1.60
- Resistance Level
- TLSI $5.32
- LANV $1.82
- Average True Range (ATR)
- TLSI 0.36
- LANV 0.16
- MACD
- TLSI -0.04
- LANV -0.01
- Stochastic Oscillator
- TLSI 18.49
- LANV 32.26
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.